Thiothixene

Generic name: Pronounced as (thye oh thix' een)
Brand names
  • Navane®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 07/15/2017

Studies have shown that older adults with dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and that may cause changes in mood and personality) who take antipsychotics (medications for mental illness) such as thiothixene have an increased chance of death during treatment.

Thiothixene is not approved by the Food and Drug Administration (FDA) for the treatment of behavior problems in older adults with dementia. Talk to the doctor who prescribed this medication if you, a family member, or someone you care for has dementia and is taking thiothixene. For more information, visit the FDA website: http://www.fda.gov/Drugs

Thiothixene is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Thiothixene is in a group of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.

Thiothixene comes as a capsule to take by mouth. It is usually taken one to three times a day. Take thiothixene at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take thiothixene exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor will probably start you on a low dose of thiothixene and gradually increase your dose.

Thiothixene may help control your condition but will not cure it. Continue to take thiothixene even if you feel well. Do not stop taking thiothixene without talking to your doctor.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking thiothixene,

  • tell your doctor and pharmacist if you are allergic to thiothixene, phenothiazines such as chlorpromazine, fluphenazine, perphenazine, prochlorperazine (Compazine), promethazine (Phenergan), thioridazine, and trifluoperazine; or any other medications.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, and nutritional supplements you are taking or plan to take. Be sure to mention any of the following: antidepressants; antihistamines; atropine (in Motofen, in Lomotil, in Lonox); epinephrine (Epipen); ipratropium (Atrovent); medications for anxiety, high blood pressure, irritable bowel disease, mental illness, motion sickness, Parkinson's disease, ulcers, or urinary problems; certain medications for seizures such as carbamazepine (Epitol, Equetro, Tegretol), phenobarbital, and phenytoin (Dilantin); narcotic medications for pain; rifabutin (Mycobutin); rifampin (Rifadin, in Rifamate, in Rifater); sedatives; sleeping pills; and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor what herbal products you are taking, especially St. John's wort.

  • tell your doctor if you have or have ever had any condition that affects your blood cells. Your doctor may tell you not to take thiothixene.

  • tell your doctor if you have or have ever had trouble keeping your balance, seizures, breast cancer, or heart disease. Also tell your doctor if you are experiencing alcohol withdrawal (symptoms that a person may experience when he/she suddenly stops drinking alcohol after drinking heavily or for a long time), or if you have ever had to stop taking a medication for mental illness due to severe side effects.

  • tell your doctor if you are pregnant, especially if you are in the last few months of your pregnancy, or if you plan to become pregnant or are breast-feeding. If you become pregnant while taking thiothixene, call your doctor. Thiothixene. may cause problems in newborns following delivery if it is taken during the last months of pregnancy.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking thiothixene.

  • you should know that this medication may make you drowsy and may affect your thinking and movements, especially at the beginning of your treatment. Do not drive a car or operate machinery until you know how this medication affects you.

  • ask your doctor about the safe use of alcohol during your treatment with thiothixene. Alcohol can make the side effects of thiothixene worse.

  • plan to avoid unnecessary or prolonged exposure to sunlight and to wear protective clothing, sunglasses, and sunscreen. Thiothixene may make your skin sensitive to sunlight.

  • you should know that thiothixene may make it harder for your body to cool down when it gets very hot. Tell your doctor if you plan to do vigorous exercise or be exposed to extreme heat.

  • you should know that thiothixene may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. This is more common when you first start taking thiothixene. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Thiothixene may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • dizziness, lightheadedness, feeling unsteady, or having trouble keeping your balance

    • blurred vision

    • dry mouth

    • excess saliva

    • stuffed nose

    • nausea

    • vomiting

    • constipation

    • diarrhea

    • changes in appetite

    • excessive thirst

    • weight gain

    • widening or narrowing of the pupils (black circles in the middle of the eyes)

    • blank facial expression

    • shuffling walk

    • unusual, slowed, or uncontrollable movements of any part of the body

    • restlessness

    • agitation

    • difficulty falling asleep or staying asleep

    • swelling of the arms, hands, feet, ankles, or lower legs

    • breast enlargement

    • breast milk production

    • missed or irregular menstrual periods

    • decreased sexual ability in men

    • weakness

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:

    • fever

    • muscle stiffness

    • falling

    • confusion

    • fast or irregular heartbeat

    • sweating

    • neck cramps

    • tongue that sticks out of the mouth

    • tightness in the throat

    • difficulty breathing or swallowing

    • fine, worm-like tongue movements

    • uncontrollable, rhythmic face, mouth, or jaw movements

    • seizures

    • rash

    • hives

    • itching

    • vision loss, especially at night

    • seeing everything with a brown tint

  • Thiothixene may cause other side effects. Tell your doctor if you have any unusual problems during your treatment with thiothixene.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • muscle twitching

  • drowsiness

  • dizziness

  • tightness of the neck muscles

  • uncontrollable movements of a part of the body

  • excess saliva

  • difficulty swallowing

  • difficulty walking

  • coma (loss of consciousness for a period of time)

Keep all appointments with your doctor.

Thiothixene may interfere with the results of home pregnancy tests. Talk to your doctor if you think you might be pregnant during your treatment with thiothixene. Do not try to test for pregnancy at home.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Thiothixene can be decreased when combined with Moxifloxacin.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Thiothixene can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The serum concentration of Thiothixene can be decreased when it is combined with Leflunomide.
Nevirapine Nevirapine The metabolism of Thiothixene can be decreased when combined with Nevirapine.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Dolasetron.
Aminophylline Aminophylline The metabolism of Thiothixene can be decreased when combined with Aminophylline.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Anagrelide.
Cilostazol Cilostazol The metabolism of Thiothixene can be decreased when combined with Cilostazol.
Clopidogrel Clopidogrel The metabolism of Thiothixene can be decreased when combined with Clopidogrel.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Thiothixene.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Thiothixene can be decreased when combined with Conjugated estrogens.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Guanfacine is combined with Thiothixene.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Thiothixene.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Thiothixene.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Acebutolol.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Thiothixene.
Ranitidine Ranitidine The metabolism of Thiothixene can be decreased when combined with Ranitidine.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Thiothixene.
Rizatriptan Rizatriptan The risk or severity of adverse effects can be increased when Rizatriptan is combined with Thiothixene.
Sumatriptan Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Thiothixene.
Tacrolimus Tacrolimus The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Thiothixene.
Tizanidine Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Thiothixene.
Zolmitriptan Zolmitriptan The metabolism of Thiothixene can be decreased when combined with Zolmitriptan.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Thiothixene.
Fluconazole Injection Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Thiothixene.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Thiothixene.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Thiothixene.
Interferon Beta-1b Injection Interferon Beta-1b Injection The metabolism of Thiothixene can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The metabolism of Thiothixene can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Thiothixene can be increased when combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of adverse effects can be increased when Metoclopramide is combined with Thiothixene.
Metronidazole Injection Metronidazole Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Thiothixene.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Thiothixene.
Altretamine Altretamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Thiothixene.
Cyclosporine Cyclosporine Cyclosporine may increase the neurotoxic activities of Thiothixene.
Ondansetron Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Thiothixene.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Granisetron.
Olanzapine Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Thiothixene.
Alosetron Alosetron The metabolism of Thiothixene can be decreased when combined with Alosetron.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Dofetilide.
Entacapone Entacapone The therapeutic efficacy of Thiothixene can be decreased when used in combination with Entacapone.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Thiothixene.
Oxcarbazepine Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Thiothixene.
Zaleplon Zaleplon The risk or severity of adverse effects can be increased when Zaleplon is combined with Thiothixene.
Anakinra Anakinra The metabolism of Thiothixene can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Desloratadine is combined with Thiothixene.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Thiothixene.
Trimipramine Trimipramine The risk or severity of adverse effects can be increased when Trimipramine is combined with Thiothixene.
Etanercept Injection Etanercept Injection The metabolism of Thiothixene can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Thiothixene can be increased when combined with Modafinil.
Escitalopram Escitalopram The risk or severity of adverse effects can be increased when Escitalopram is combined with Thiothixene.
Zonisamide Zonisamide The risk or severity of adverse effects can be increased when Zonisamide is combined with Thiothixene.
Adalimumab Injection Adalimumab Injection The metabolism of Thiothixene can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of adverse effects can be increased when Aripiprazole is combined with Thiothixene.
Atomoxetine Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Thiothixene.
Dexmethylphenidate Dexmethylphenidate The risk or severity of adverse effects can be increased when Thiothixene is combined with Dexmethylphenidate.
Atazanavir Atazanavir The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Thiothixene.
Almotriptan Almotriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Thiothixene.
Eletriptan Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Thiothixene.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Thiothixene.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Thiothixene.
Alfuzosin Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Thiothixene.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Thiothixene can be decreased when combined with Interferon beta-1a.
Memantine Memantine The therapeutic efficacy of Memantine can be decreased when used in combination with Thiothixene.
Tegaserod Tegaserod The metabolism of Thiothixene can be decreased when combined with Tegaserod.
Frovatriptan Frovatriptan The metabolism of Thiothixene can be decreased when combined with Frovatriptan.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Gemifloxacin.
Apomorphine Injection Apomorphine Injection The therapeutic efficacy of Apomorphine can be decreased when used in combination with Thiothixene.
Infliximab Injection Infliximab Injection The metabolism of Thiothixene can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Thiothixene.
Duloxetine Duloxetine The risk or severity of adverse effects can be increased when Duloxetine is combined with Thiothixene.
Trospium Trospium Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Cinacalcet Cinacalcet The metabolism of Thiothixene can be decreased when combined with Cinacalcet.
Erlotinib Erlotinib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Erlotinib.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Thiothixene is combined with Eszopiclone.
Solifenacin Solifenacin Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Voriconazole Voriconazole The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Thiothixene.
Dextroamphetamine Dextroamphetamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Thiothixene.
Entecavir Entecavir The metabolism of Thiothixene can be decreased when combined with Entecavir.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The metabolism of Thiothixene can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Thiothixene can be increased when it is combined with Peginterferon alfa-2b.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Thiothixene.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Thiothixene.
Ramelteon Ramelteon The risk or severity of adverse effects can be increased when Ramelteon is combined with Thiothixene.
Darifenacin Darifenacin Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Thiothixene.
Pregabalin Pregabalin The therapeutic efficacy of Thiothixene can be increased when used in combination with Pregabalin.
Deferasirox Deferasirox The serum concentration of Thiothixene can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine The metabolism of Thiothixene can be increased when combined with Phenylephrine.
Felbamate Felbamate The risk or severity of adverse effects can be increased when Felbamate is combined with Thiothixene.
Ranolazine Ranolazine The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Thiothixene can be increased when combined with Abatacept.
Rasagiline Rasagiline The therapeutic efficacy of Thiothixene can be decreased when used in combination with Rasagiline.
Imatinib Imatinib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Imatinib.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Thiothixene.
Paliperidone Paliperidone The risk or severity of adverse effects can be increased when Paliperidone is combined with Thiothixene.
Bortezomib Bortezomib The metabolism of Thiothixene can be decreased when combined with Bortezomib.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Thiothixene can be increased when combined with Insulin glulisine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Oxaliplatin.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Thiothixene.
Primaquine Primaquine The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Primaquine.
Bismuth Subsalicylate Bismuth Subsalicylate Bismuth subsalicylate may increase the neurotoxic activities of Thiothixene.
Pemetrexed Injection Pemetrexed Injection The metabolism of Thiothixene can be decreased when combined with Pemetrexed.
Dimenhydrinate Dimenhydrinate The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Thiothixene.
Lisdexamfetamine Lisdexamfetamine Thiothixene may decrease the stimulatory activities of Lisdexamfetamine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Thiothixene can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Thiothixene.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Lapatinib Lapatinib The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Thiothixene.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Thiothixene is combined with Levocetirizine.
Dasatinib Dasatinib The metabolism of Thiothixene can be decreased when combined with Dasatinib.
Mexiletine Mexiletine The metabolism of Thiothixene can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Thiothixene can be increased when combined with Armodafinil.
Nilotinib Nilotinib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Nilotinib.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Toremifene.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Thiothixene.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiothixene.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine The risk or severity of adverse effects can be increased when Thiothixene is combined with Desvenlafaxine.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Thiothixene.
Flecainide Flecainide The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Thiothixene can be increased when combined with Certolizumab pegol.
Praziquantel Praziquantel The metabolism of Thiothixene can be decreased when combined with Praziquantel.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Thiothixene.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Thiothixene.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Thiothixene.
Milnacipran Milnacipran The risk or severity of adverse effects can be increased when Thiothixene is combined with Milnacipran.
Fesoterodine Fesoterodine Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Degarelix.
Betaxolol Betaxolol The metabolism of Thiothixene can be decreased when combined with Betaxolol.
Iloperidone Iloperidone The risk or severity of adverse effects can be increased when Thiothixene is combined with Iloperidone.
Lacosamide Lacosamide The risk or severity of adverse effects can be increased when Thiothixene is combined with Lacosamide.
Dronedarone Dronedarone The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Dronedarone.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Thiothixene.
Palonosetron Injection Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Thiothixene.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Romidepsin.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Golimumab Injection Golimumab Injection The metabolism of Thiothixene can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Thiothixene.
Asenapine Asenapine The risk or severity of adverse effects can be increased when Thiothixene is combined with Asenapine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Thiothixene.
Albendazole Albendazole The metabolism of Thiothixene can be decreased when combined with Albendazole.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Thiothixene.
Tocilizumab Injection Tocilizumab Injection The metabolism of Thiothixene can be increased when combined with Tocilizumab.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Eribulin.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Thiothixene.
Lurasidone Lurasidone The risk or severity of adverse effects can be increased when Thiothixene is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Thiothixene can be decreased when combined with Acetaminophen.
Vilazodone Vilazodone The risk or severity of adverse effects can be increased when Thiothixene is combined with Vilazodone.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Thiothixene.
Rilpivirine Rilpivirine The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Rilpivirine.
Cyclophosphamide Injection Cyclophosphamide Injection Cyclophosphamide may increase the neurotoxic activities of Thiothixene.
Abiraterone Abiraterone The serum concentration of Thiothixene can be increased when it is combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Triptorelin.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Vandetanib.
Clobazam Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Thiothixene.
Vemurafenib Vemurafenib The serum concentration of Thiothixene can be increased when it is combined with Vemurafenib.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Thiothixene.
Crizotinib Crizotinib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Crizotinib.
Cabergoline Cabergoline The therapeutic efficacy of Thiothixene can be decreased when used in combination with Cabergoline.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Thiothixene.
Mirabegron Mirabegron The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Mirabegron.
Teriflunomide Teriflunomide The serum concentration of Thiothixene can be decreased when it is combined with Teriflunomide.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Bedaquiline.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Thiothixene is combined with Pomalidomide.
Dabrafenib Dabrafenib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Dabrafenib.
Levomilnacipran Levomilnacipran The risk or severity of adverse effects can be increased when Thiothixene is combined with Levomilnacipran.
Vortioxetine Vortioxetine The risk or severity of adverse effects can be increased when Thiothixene is combined with Vortioxetine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Simeprevir Simeprevir The metabolism of Thiothixene can be decreased when combined with Simeprevir.
Dapagliflozin Dapagliflozin The metabolism of Thiothixene can be decreased when combined with Dapagliflozin.
Apremilast Apremilast The metabolism of Thiothixene can be increased when combined with Apremilast.
Ceritinib Ceritinib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Thiothixene can be increased when combined with Siltuximab.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Thiothixene is combined with Eslicarbazepine.
Belinostat Injection Belinostat Injection The metabolism of Thiothixene can be increased when combined with Belinostat.
Hydrocodone Hydrocodone Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Suvorexant Suvorexant Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The metabolism of Thiothixene can be decreased when combined with Peginterferon beta-1a.
Methamphetamine Methamphetamine The risk or severity of adverse effects can be increased when Metamfetamine is combined with Thiothixene.
Tasimelteon Tasimelteon The risk or severity of adverse effects can be increased when Thiothixene is combined with Tasimelteon.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Thiothixene.
Secukinumab Injection Secukinumab Injection The metabolism of Thiothixene can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Thiothixene.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Thiothixene can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Lenvatinib.
Panobinostat Panobinostat The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Panobinostat.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Thiothixene.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Ivabradine.
Flibanserin Flibanserin The risk or severity of adverse effects can be increased when Thiothixene is combined with Flibanserin.
Brexpiprazole Brexpiprazole The risk or severity of adverse effects can be increased when Thiothixene is combined with Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Thiothixene.
Cariprazine Cariprazine The risk or severity of adverse effects can be increased when Thiothixene is combined with Cariprazine.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Thiothixene can be increased when combined with Insulin degludec.
Osimertinib Osimertinib The serum concentration of Thiothixene can be decreased when it is combined with Osimertinib.
Brivaracetam Injection Brivaracetam Injection The risk or severity of adverse effects can be increased when Thiothixene is combined with Brivaracetam.
Pimavanserin Pimavanserin The therapeutic efficacy of Pimavanserin can be decreased when used in combination with Thiothixene.
Obeticholic Acid Obeticholic Acid The metabolism of Thiothixene can be decreased when combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Thiothixene.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Thiothixene.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Ribociclib.
Doxepin (Insomnia) Doxepin (Insomnia) The risk or severity of adverse effects can be increased when Doxepin is combined with Thiothixene.
Deutetrabenazine Deutetrabenazine The risk or severity of adverse effects can be increased when Thiothixene is combined with Deutetrabenazine.
Safinamide Safinamide The therapeutic efficacy of Thiothixene can be decreased when used in combination with Safinamide.
Midostaurin Midostaurin The metabolism of Thiothixene can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Thiothixene can be decreased when combined with Enasidenib.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Delafloxacin.
Tetrabenazine Tetrabenazine The risk or severity of adverse effects can be increased when Thiothixene is combined with Tetrabenazine.
Buprenorphine Injection Buprenorphine Injection Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Lofexidine Lofexidine The therapeutic efficacy of Thiothixene can be increased when used in combination with Lofexidine.
Eliglustat Eliglustat The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Eliglustat.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Encorafenib.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Thiothixene.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Ivosidenib.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiothixene.
Stiripentol Stiripentol The risk or severity of adverse effects can be increased when Thiothixene is combined with Stiripentol.
Gilteritinib Gilteritinib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Glasdegib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection Paclitaxel may increase the neurotoxic activities of Thiothixene.
Rifamycin Rifamycin The metabolism of Thiothixene can be decreased when combined with Rifamycin.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Thiothixene can be increased when combined with Emapalumab.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Thiothixene can be decreased when combined with Acyclovir.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Thiothixene is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of adverse effects can be increased when Thiothixene is combined with Solriamfetol.
Triclabendazole Triclabendazole The metabolism of Thiothixene can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Entrectinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Thiothixene.
Pitolisant Pitolisant Pitolisant may increase the QTc-prolonging activities of Thiothixene.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Thiothixene.
Phenytoin Injection Phenytoin Injection The risk or severity of adverse effects can be increased when Phenytoin is combined with Thiothixene.
Fosphenytoin Injection Fosphenytoin Injection The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Thiothixene.
Lumateperone Lumateperone The risk or severity of adverse effects can be increased when Thiothixene is combined with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of adverse effects can be increased when Thiothixene is combined with Lasmiditan.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Thiothixene.
Capmatinib Capmatinib The metabolism of Thiothixene can be decreased when combined with Capmatinib.
Lemborexant Lemborexant The risk or severity of adverse effects can be increased when Thiothixene is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of adverse effects can be increased when Fenfluramine is combined with Thiothixene.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Fostemsavir.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Thiothixene.
Opicapone Opicapone The therapeutic efficacy of Opicapone can be decreased when used in combination with Thiothixene.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Thiothixene can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection Thiothixene may increase the neurotoxic activities of Naxitamab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Relugolix.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Thiothixene is combined with Viloxazine.
Theophylline Theophylline The metabolism of Thiothixene can be decreased when combined with Theophylline.
Naproxen Naproxen The metabolism of Thiothixene can be decreased when combined with Naproxen.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Thiothixene.
Phenobarbital Phenobarbital The risk or severity of adverse effects can be increased when Phenobarbital is combined with Thiothixene.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Thiothixene.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Thiothixene.
Primidone Primidone The metabolism of Thiothixene can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of adverse effects can be increased when Thiothixene is combined with Methsuximide.
Diethylpropion Diethylpropion Thiothixene may decrease the stimulatory activities of Diethylpropion.
Chlorpromazine Chlorpromazine The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Thiothixene.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Thiothixene.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Thiothixene.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Thiothixene.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Thiothixene.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Thiothixene.
Carmustine Carmustine The metabolism of Thiothixene can be decreased when combined with Carmustine.
Amantadine Amantadine The therapeutic efficacy of Amantadine can be decreased when used in combination with Thiothixene.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Thiothixene.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Thiothixene.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Thiothixene.
Bromocriptine Bromocriptine The therapeutic efficacy of Thiothixene can be decreased when used in combination with Bromocriptine.
Tranylcypromine Tranylcypromine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Thiothixene.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Thiothixene.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Thiothixene.
Ergoloid Mesylates Ergoloid Mesylates The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Thiothixene.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Prochlorperazine Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Thiothixene.
Thioridazine Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Thiothixene.
Trifluoperazine Trifluoperazine The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Thiothixene.
Oxycodone Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Thiothixene.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Thiothixene.
Oxybutynin Oxybutynin Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine Benztropine The risk or severity of adverse effects can be increased when Thiothixene is combined with Benzatropine.
Maprotiline Maprotiline The risk or severity of adverse effects can be increased when Maprotiline is combined with Thiothixene.
Trihexyphenidyl Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Thiothixene.
Orphenadrine Orphenadrine Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Thiothixene.
Azathioprine Azathioprine The metabolism of Thiothixene can be decreased when combined with Azathioprine.
Fluphenazine Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiothixene.
Phentermine Phentermine Thiothixene may decrease the stimulatory activities of Phentermine.
Methylphenidate Methylphenidate The risk or severity of adverse effects can be increased when Thiothixene is combined with Methylphenidate.
Amoxapine Amoxapine The risk or severity of adverse effects can be increased when Amoxapine is combined with Thiothixene.
Carbamazepine Carbamazepine The metabolism of Thiothixene can be increased when combined with Carbamazepine.
Molindone Molindone The risk or severity of adverse effects can be increased when Molindone is combined with Thiothixene.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Thiothixene.
Cimetidine Cimetidine The metabolism of Thiothixene can be decreased when combined with Cimetidine.
Warfarin Warfarin The metabolism of Thiothixene can be decreased when combined with Warfarin.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Clonazepam is combined with Thiothixene.
Loperamide Loperamide The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Loperamide.
Promethazine Promethazine Promethazine may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Griseofulvin Griseofulvin The metabolism of Thiothixene can be increased when combined with Griseofulvin.
Digoxin Digoxin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Thiothixene.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Thiothixene.
Chloroquine Chloroquine The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Chloroquine.
Quinine Quinine The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Thiothixene.
Triamterene Triamterene The metabolism of Thiothixene can be decreased when combined with Triamterene.
Clindamycin Injection Clindamycin Injection Clindamycin may increase the neurotoxic activities of Thiothixene.
Secobarbital Secobarbital The risk or severity of adverse effects can be increased when Secobarbital is combined with Thiothixene.
Desipramine Desipramine The risk or severity of adverse effects can be increased when Desipramine is combined with Thiothixene.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Thiothixene.
Imipramine Imipramine The risk or severity of adverse effects can be increased when Imipramine is combined with Thiothixene.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Thiothixene.
Procainamide Procainamide The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Procainamide.
Isoniazid Isoniazid The metabolism of Thiothixene can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Thiothixene can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Disopyramide.
Valproic Acid Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Thiothixene.
Tamoxifen Tamoxifen The metabolism of Thiothixene can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Thiothixene.
Methimazole Methimazole The metabolism of Thiothixene can be decreased when combined with Methimazole.
Dextromethorphan Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Thiothixene.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Thiothixene.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Thiothixene.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Cyproheptadine Cyproheptadine Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Thiothixene.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Thiothixene.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Thiothixene.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Dantrolene is combined with Thiothixene.
Chlorzoxazone Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Thiothixene.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Thiothixene.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Thiothixene.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Thiothixene.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Thiothixene can be decreased when combined with Propranolol.
Pseudoephedrine Pseudoephedrine Thiothixene may decrease the stimulatory activities of Pseudoephedrine.
Nortriptyline Nortriptyline The risk or severity of adverse effects can be increased when Nortriptyline is combined with Thiothixene.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Thiothixene.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Thiothixene.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Thiothixene.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Thiothixene.
Flavoxate Flavoxate Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Fluorouracil.
Dacarbazine Dacarbazine The metabolism of Thiothixene can be decreased when combined with Dacarbazine.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Thiothixene.
Ketoconazole Ketoconazole The metabolism of Thiothixene can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Thiothixene is combined with Pyrantel.
Vincristine Injection Vincristine Injection Vincristine may increase the neurotoxic activities of Thiothixene.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Thiothixene.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Thiothixene.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Thiothixene.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Thiothixene.
Dicyclomine Dicyclomine Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Diltiazem Diltiazem The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Diltiazem.
Nifedipine Nifedipine The metabolism of Thiothixene can be decreased when combined with Nifedipine.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Thiothixene.
Verapamil Verapamil The metabolism of Thiothixene can be decreased when combined with Verapamil.
Pindolol Pindolol The risk or severity of adverse effects can be increased when Pindolol is combined with Thiothixene.
Streptozocin Streptozocin The metabolism of Thiothixene can be increased when combined with Streptozocin.
Etoposide Etoposide The metabolism of Thiothixene can be decreased when combined with Etoposide.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Indapamide is combined with Thiothixene.
Nafcillin Injection Nafcillin Injection The metabolism of Thiothixene can be increased when combined with Nafcillin.
Pentoxifylline Pentoxifylline The metabolism of Thiothixene can be decreased when combined with Pentoxifylline.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Pentamidine.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Leuprolide.
Gemfibrozil Gemfibrozil The metabolism of Thiothixene can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The metabolism of Thiothixene can be decreased when combined with Guanabenz.
Pimozide Pimozide The risk or severity of adverse effects can be increased when Pimozide is combined with Thiothixene.
Amiodarone Amiodarone The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Thiothixene.
Ciprofloxacin Ciprofloxacin The metabolism of Thiothixene can be decreased when combined with Ciprofloxacin.
Diclofenac Diclofenac The metabolism of Thiothixene can be decreased when combined with Diclofenac.
Fluoxetine Fluoxetine Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Nimodipine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The metabolism of Thiothixene can be decreased when combined with Interferon alfa-2b.
Clozapine Clozapine The risk or severity of adverse effects can be increased when Clozapine is combined with Thiothixene.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Estazolam is combined with Thiothixene.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Ofloxacin.
Didanosine Didanosine Didanosine may increase the neurotoxic activities of Thiothixene.
Clarithromycin Clarithromycin The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Clarithromycin.
Felodipine Felodipine The risk or severity of QTc prolongation can be increased when Felodipine is combined with Thiothixene.
Nabumetone Nabumetone The metabolism of Thiothixene can be decreased when combined with Nabumetone.
Teniposide Injection Teniposide Injection Teniposide may increase the neurotoxic activities of Thiothixene.
Itraconazole Itraconazole The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Thiothixene.
Sotalol Sotalol The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Sotalol.
Zolpidem Zolpidem Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Isradipine Isradipine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Thiothixene.
Omeprazole Omeprazole The metabolism of Thiothixene can be increased when combined with Omeprazole.
Cisapride Cisapride The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Cisapride.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Thiothixene.
Venlafaxine Venlafaxine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Thiothixene.
Stavudine Stavudine Stavudine may increase the neurotoxic activities of Thiothixene.
Fluvoxamine Fluvoxamine The metabolism of Thiothixene can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The risk or severity of adverse effects can be increased when Nefazodone is combined with Thiothixene.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Thiothixene.
Losartan Losartan The risk or severity of QTc prolongation can be increased when Losartan is combined with Thiothixene.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Thiothixene.
Vinorelbine Injection Vinorelbine Injection Vinorelbine may increase the neurotoxic activities of Thiothixene.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Thiothixene.
Nicardipine Nicardipine Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Bupropion is combined with Thiothixene.
Ticlopidine Ticlopidine The metabolism of Thiothixene can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Saquinavir.
Riluzole Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Thiothixene.
Ritonavir Ritonavir The metabolism of Thiothixene can be increased when combined with Ritonavir.
Clomipramine Clomipramine The risk or severity of adverse effects can be increased when Clomipramine is combined with Thiothixene.
Zafirlukast Zafirlukast The metabolism of Thiothixene can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Thiothixene.
Zileuton Zileuton The metabolism of Thiothixene can be decreased when combined with Zileuton.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Thiothixene can be increased when combined with Insulin lispro.
Pramipexole Pramipexole The therapeutic efficacy of Pramipexole can be decreased when used in combination with Thiothixene.
Donepezil Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Thiothixene.
Nelfinavir Nelfinavir The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Thiothixene.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Azithromycin.
Carvedilol Carvedilol The metabolism of Thiothixene can be decreased when combined with Carvedilol.
Flutamide Flutamide The metabolism of Thiothixene can be decreased when combined with Flutamide.
Selegiline Selegiline The therapeutic efficacy of Thiothixene can be decreased when used in combination with Selegiline.
Sertraline Sertraline The risk or severity of adverse effects can be increased when Sertraline is combined with Thiothixene.
Propafenone Propafenone The metabolism of Thiothixene can be decreased when combined with Propafenone.
Ropinirole Ropinirole The therapeutic efficacy of Ropinirole can be decreased when used in combination with Thiothixene.
Quetiapine Quetiapine The risk or severity of adverse effects can be increased when Quetiapine is combined with Thiothixene.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Thiothixene.
Paroxetine Paroxetine The risk or severity of adverse effects can be increased when Paroxetine is combined with Thiothixene.
Tolcapone Tolcapone The therapeutic efficacy of Thiothixene can be decreased when used in combination with Tolcapone.
Citalopram Citalopram The risk or severity of adverse effects can be increased when Citalopram is combined with Thiothixene.
Efavirenz Efavirenz The risk or severity of adverse effects can be increased when Efavirenz is combined with Thiothixene.
Rosiglitazone Rosiglitazone The metabolism of Thiothixene can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine Tolterodine may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Thalidomide Thalidomide Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Thiothixene.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Thiothixene.
Rabeprazole Rabeprazole The metabolism of Thiothixene can be increased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Thiothixene can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists